# FDA recall D-0620-2024

> **SoloVital** · Class I · drug recall initiated 2024-07-12.

## Product

Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

## Reason for recall

Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-0620-2024
- **Recalling firm:** SoloVital
- **Classification:** Class I
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2024-07-12
- **Report date:** 2024-08-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Chula Vista, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0620-2024

## Citation

> AI Analytics. FDA recall D-0620-2024. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0620-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*